E-LIB Suche - Ergebnisse für: Ponferrada, A.

1

P989 Switching from intravenous to subcutaneous vedolizumab..:

Gros, B ; Manceñido Marcos, N ; Guardiola, J...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1793-i1795 , 2024

Link: https://doi.org/10.1093/..

2

P786 Evaluation of the efficacy and safety of the use of su..:

Escobar, J ; Pérez, J ; Plaza, R...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1464-i1466 , 2024

Link: https://doi.org/10.1093/..

3

P516 Subcutaneous infliximab cut-off points in a large coho..:

Iborra, M ; Caballol, B ; Garrido, A...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1020-i1021 , 2024

Link: https://doi.org/10.1093/..

4

P822 Therapeutic Management And Risk Of Colectomy In Patien..:

Mesonero Gismero, F ; López-García, A ; Miranda-Bautista, J...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1530-i1532 , 2024

Link: https://doi.org/10.1093/..

5

P844 Frequency and effectiveness of dose de-escalation of b..:

Rubín De Célix, C ; Ricart, E ; Martín-Arranz, M D...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1567-i1569 , 2024

Link: https://doi.org/10.1093/..

6

DOP75 Frequency and effectiveness of dose escalation of bio..:

Rubín De Célix, C ; Ricart, E ; Martín-Arranz, M D...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i211-i213 , 2024

Link: https://doi.org/10.1093/..

7

P230 Clinical characteristics, risk factors and management ..:

Madero Velázquez, L ; De Francisco, R ; Herreros, B...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i568-i569 , 2024

Link: https://doi.org/10.1093/..

8

P386 Clinical presentation, management, and evolution of ly..:

Guerra Marina, I ; Bujanda, L ; Mañosa, M...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i519-i520 , 2023

Link: https://doi.org/10.1093/..

9

DOP17 HIV infection is associated with a less aggressive ph..:

Calafat Sard, M ; Súria, C ; Mesonero, F...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i80-i81 , 2023

Link: https://doi.org/10.1093/..

10

P335 Impact of cancer therapy on the course of Inflammatory..:

Pérez Galindo, P ; Benítez, J M ; Rubín de Célix, C...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i472-i473 , 2023

Link: https://doi.org/10.1093/..

11

DOP78 Comparative study of the effectiveness of vedolizumab..:

García, M J ; Rivero, M ; Fernández-Clotet, A...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i121-i123 , 2022

Link: https://doi.org/10.1093/..

12

P606 Adherence to endoscopic surveillance guidelines for ad..:

Ballester Ferré, M P ; Mesonero, F ; Flórez-Diez, P...
Journal of Crohn's and Colitis. 15 (2021) Supplement_1 - p. S551-S552 , 2021

Link: https://doi.org/10.1093/..

13

DOP063 Serial tuberculin skin test improves the detection o..:

Taxonera, C. ; Ponferrada, A. ; Bermejo, F....
Journal of Crohn's and Colitis. 11 (2017) suppl_1 - p. S63-S63 , 2017

Link: https://doi.org/10.1093/..

14

P536 Effectiveness of the available therapeutic options in ..:

Arberas-Diez, B. ; Chaparro, M. ; Burgueño, P....
Journal of Crohn's and Colitis. 7 (2013) - p. S225 , 2013

Link: https://doi.org/10.1016/..

15

Health Care Costs of Complex Perianal Fistula in Crohn's Di..:

Chaparro, M. ; Zanotti, C. ; Burgueño, P....
Digestive Diseases and Sciences. 58 (2013) 12 - p. 3400-3406 , 2013

Link: https://doi.org/10.1007/..